{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Ridgefield",
      "address_1": "900 Ridgebury Rd",
      "reason_for_recall": "Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and  50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.",
      "address_2": "",
      "product_quantity": "6400 bottles",
      "code_info": "Lot #: 554820, Exp 5/17",
      "center_classification_date": "20161024",
      "distribution_pattern": "Nationwide",
      "state": "CT",
      "product_description": "DIPYRIDAMOLE Tablets USP, 75 mg, 100-count bottle, Rx only, Dist. by: Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-0436-25",
      "report_date": "20161102",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "recall_number": "D-0114-2017",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "75374",
      "termination_date": "20171129",
      "more_code_info": "",
      "recall_initiation_date": "20161006",
      "postal_code": "06877-1058",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}